Author： Feletou M. Martin C.A.E. Molimard M. Naline E. Germain M. Thurieau C. Fauchere J.-L. Canet E. Advenier C.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.274, Iss.1, 1995-02, pp. : 57-64
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hoe 140 and pseudo-irreversible antagonism in the rat vas deferens in vitro
European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. :
Access to resources
Recommend
Icatibant: HOE 140, JE 049, JE049
Drugs in R&D, Vol. 6, Iss. 4, 2005-01 ,pp. :
Icatibant: HOE 140, JE 049, JE049
Drugs in R&D, Vol. 5, Iss. 6, 2004-01 ,pp. :
Therapeutic potential of icatibant (HOE-140, JE-049)
By Cruden Nicholas LM Newby David E
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. :
By Amsellem C. Gormand F. Hosni R. Aloui R. Guibert B. Czarlewski W. Melac M. Lagarde M. Perrin-Fayolle M. Pacheco Y.
General Pharmacology, Vol. 27, Iss. 2, 1996-03 ,pp. :